LABCORP HOLDINGS INC. Stock Repurchase Program, Authorized Amount
LABCORP HOLDINGS INC. (LH) had Stock Repurchase Program, Authorized Amount of $2.50 billion as of 2023-12-31, per its 10-K filed 2024-02-26.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramAuthorizedAmount1 · last filed 2024-02-26
- 2023-12-31: Stock Repurchase Program, Authorized Amount $2.50B.
- 2022-12-31: Stock Repurchase Program, Authorized Amount $2.50B.
- 2021-12-31: Stock Repurchase Program, Authorized Amount $2.50B.
- 2019-09-30: Stock Repurchase Program, Authorized Amount $1.25B.
| Period end | Stock Repurchase Program, Authorized Amount |
|---|---|
| 2023-12-31 | $2.50B 10-K · filed 2024-02-26 |
| 2022-12-31 | $2.50B 10-K · filed 2023-02-28 |
| 2021-12-31 | $2.50B 10-K · filed 2022-02-25 |
| 2019-09-30 | $1.25B 10-Q · filed 2019-10-31 |
| 2019-06-30 | $1.25B 10-Q · filed 2019-08-08 |
| 2019-03-31 | $1.25B 10-Q · filed 2019-05-03 |
| 2019-02-06 | $1.25B 10-K · filed 2020-02-28 |
| 2018-09-30 | $843.50M 10-Q · filed 2018-10-30 |
| 2018-06-30 | $993.50M 10-Q · filed 2018-07-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |